Research
Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g3596 (Published 18 June 2014) Cite this as: BMJ 2014;348:g3596
Data supplement
Web Extra
Extra material supplied by the author
Files in this Data Supplement:
- Data Supplement - Supplementary tables A-C
Related articles
- Editorial Published: 18 June 2014; BMJ 348 doi:10.1136/bmj.g4047
See more
- Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and managementBMJ February 27, 2023, 380 e069717; DOI: https://doi.org/10.1136/bmj-2021-069717
- Gender dysphoria in young people is rising—and so is professional disagreementBMJ February 23, 2023, 380 p382; DOI: https://doi.org/10.1136/bmj.p382
- US task force calls for hypertension screening in all pregnanciesBMJ February 13, 2023, 380 p347; DOI: https://doi.org/10.1136/bmj.p347
- Covid-19: FDA removes US authorisation for antibody drug EvusheldBMJ February 01, 2023, 380 p264; DOI: https://doi.org/10.1136/bmj.p264
- Covid-19: US will end public health emergency on 11 May, says BidenBMJ February 01, 2023, 380 p262; DOI: https://doi.org/10.1136/bmj.p262
Cited by...
- Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: an interrupted time series study
- Hospitalization for Suicide Ideation or Attempt: 2008-2015
- Suicide and Suicide Attempts in Adolescents
- Suicidal Behavior After FDA Warnings for Antidepressants
- Authors' reply to Mosholder and colleagues
- Reservations about study on antidepressant use by young people and suicidal behaviour after FDA warnings
- Study findings on FDA antidepressant warnings and suicide attempts in young people: a false alarm?
- Proxy for suicide attempts was inappropriate in study of changes in antidepressant use after FDA warnings
- Authors' reply to Olfson and Schoenbaum, Nardo, Bartlett, Moore, Case, Gotzsche, and Barber and colleagues
- Study of study of changes in antidepressant use after FDA warnings is not reliable
- Link between FDA antidepressant warnings and increased suicide attempts in young people is questionable
- Impossible to draw meaningful conclusions from study of changes in antidepressant use after FDA warnings
- More data needed to interpret link between suicide and FDA warning on antidepressants
- Antidepressants increase, rather than decrease, risk of suicidal behaviours in younger patients
- Suicide attempts rise after FDA issues antidepressant warnings
- Communicating the harmful effects of medicines